Neoadjuvant chemoimmunotherapy in non-small cell lung cancer: evolving resectability criteria, biomarker-driven postoperative management, and emerging therapeutic strategies

Neoadjuvant chemoimmunotherapy (chemo-IO) has fundamentally reshaped the treatment paradigm for resectable non-small cell lung cancer (NSCLC), challenging long-held surgical boundaries and redefining what constitutes “resectable” disease. Trials such as CheckMate-816, KEYNOTE-671, and AEGEAN have de...

Full description

Bibliographic Details

Main Authors:	Akshay Patel, Babu Naidu, Gary Middleton, Eleni Karapanagiotou, Andrea Bille, Marc de Perrot, Eleni Josephides, Elliot Wakeam, Savvas Lampridis
Format:	Artigo
Language:	Inglês
Published:	BMJ Publishing Group 2026-02-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/14/2/e014098.full
Tags:	Add Tag No Tags, Be the first to tag this record!